Debates of November 1, 2012 (day 27)
QUESTION 277-17(3): DIABETES PREVENTION AND TREATMENT PROGRAMS
Thank you, Mr. Speaker. In follow-up to my Member’s statement, the Auditor General has noted that Health and Social Services did not have a territory-wide strategy to manage and prevent diabetes. That is part of the Chronic Disease Management Model which was due to be implemented this year. I’d like to ask the Minister has that happened and, if not, when will this be implemented.
Thank you, Mrs. Groenewegen. The honourable Minister of Health and Social Services, Mr. Beaulieu.
Mahsi cho, Mr. Speaker. The department is working with the health authorities to run a couple of pilot projects. We’re running a pilot project here, a pilot project in the Sahtu on diabetes, and we’re hoping that from reviewing the results of the pilot project, we’re going to be able to expand diabetes programs across the territory.
I thank the Minister for that. I’ll be interested to hear the results of those pilot projects. There are clinical practice guidelines for diabetes. How do we monitor whether health authorities are following these guidelines and how do we know if our efforts to control diabetes are working? What kind of monitoring do we have?
As the Member indicated, clinical practice guidelines are used to determine how we are treating diabetes. I don’t have the monitoring information here with me, but I do know that we get information on where the diabetes is across the Territories, the prevalence of diabetes from region to region.
Managing and preventing chronic diseases is a major issue for our health system. Diabetes is only one of our problems. What still needs to be done before a full Chronic Disease Management Model is ruled out and what are the obstacles to that rollout?
In 2011-2012 the department worked on the Home Care Enhancement and Aboriginal Diabetes Initiative. We spent $77,500 on that initiative to develop a Chronic Disease Strategy, and diabetes is a part of the overall Chronic Disease Strategy which includes cardiovascular and cancer.
Thank you, Mr. Beaulieu. Final supplementary, Mrs. Groenewegen.
That’s okay. Thank you.
The honourable Member for Range Lake, Mr. Dolynny.